# CytomX Therapeutics, Inc. (CTMX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CTMX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 11.68M | $ -38.91M | $ -43.62M | $ 5.70M | $ 302.07M |
| 2025 | $ 78.02M | $ -17.78M | $ -77.62M | $ 4.24M | $ 99.01M |
| 2024 | $ 145.16M | $ 33.50M | $ -90.96M | $ 9.39M | $ -456.0K |
| 2023 | $ 109.44M | $ -615.2K | $ -61.50M | $ 13.97M | $ -47.45M |
| 2022 | $ 59.39M | $ -110.95M | $ -125.71M | $ 18.06M | $ -85.75M |
| 2021 | $ 82.70M | $ -99.38M | $ -143.40M | $ 21.67M | $ -459.0K |
| 2020 | $ 127.85M | $ -41.89M | $ 3.76M | $ 24.87M | $ -7.77M |
| 2019 | $ 74.20M | $ -131.97M | $ -185.84M | $ 27.68M | $ 51.11M |
| 2018 | $ 78.58M | $ -111.74M | $ -104.74M | $ 0 | $ 130.88M |
| 2017 | $ 96.48M | $ -58.06M | $ 227.42M | $ 0 | $ 69.90M |
| 2016 | $ 20.70M | $ -81.04M | $ -5.79M | $ 0 | $ 78.48M |
| 2015 | $ 10.83M | $ -49.67M | $ -40.73M | $ 0 | $ 126.07M |
| 2014 | $ 7.17M | $ -45.94M | $ 42.59M | $ 2.99M | $ -78.54M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.26 |
| Current Ratio | 9.36 |

## Other views

- [Metrics](https://sponda.capital/en/CTMX.md)
- [Charts](https://sponda.capital/en/CTMX/charts.md)
- [Compare](https://sponda.capital/en/CTMX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.